2 days ago at Macroaxis 
By Achuva Shats
Eaton Vance current daily volatility is 0.74 percent, with beta of 0.32 and alpha of 0.02 over Russell 2000 . We consider Eaton Vance very steady. Eaton Vance Tax secures Sharpe Ratio (or Efficiency) of 0.0045 which denotes the organization had 0.0045% of return per unit of risk over the last 1 month. Our philosophy towards predicting volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Eaton Vance Tax Advantaged Divi which you can use to evaluate future volatility of the firm. Please confirm Eaton Vance Tax Coefficient Of Variation of 3528.69, Mean Deviation of 0.5347 and Downside Deviation of 0.8706 to check if risk estimate we provide are consistent with the epected return of 0.0033%.
 Eaton Vance  leverage ideas   eaton vance financial services asset management
  2 days ago at Macroaxis 
By Achuva Shats
The firm chance of financial distress is now about 37.0 percent. We consider Esoft Systems moderately volatile. Esoft Systems AS secures Sharpe Ratio (or Efficiency) of 0.0 which denotes the organization had 0.0% of return per unit of risk over the last 1 month. Our philosophy towards predicting volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Esoft Systems AS which you can use to evaluate future volatility of the firm. Please confirm Esoft Systems AS Mean Deviation of 2.09, Coefficient Of Variation of 1349.55 and Downside Deviation of 8.82 to check if risk estimate we provide are consistent with the epected return of 0.0%.
 Esoft Systems  forecast ideas   esoft systems consumer cyclical advertising agencies
  2 days ago at Macroaxis 
By Ellen Johnson
Tribune Publishing is at this time traded for8.26. The entity stock is not elastic to its hype. The firm is projected not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 2488.89%. The immediate return on the next news is projected to be very small where as daily expected return is at this time at 0.02%. The volatility of relative hype elasticity to Tribune Publishing is about 1028.57%%. The volatility of related hype on Tribune Publishing is about 1028.57% with expected price after next announcement by competition of 8.26. Given the investment horizon of 30 days, the next projected press release will be in about 6 days. What is Tribune Publishing Target Price Odds to finish over Current Price? Proceeding from normal probability distribution, the odds of Tribune Publishing to move above current price in 30 days from now is about 23.7%. The Tribune Publishing Company probability density function shows the probability of Tribune Publishing Stock to fall within a particular range of prices over 30 days . Given the investment horizon of 30 days, Tribune Publishing has beta of 0.1627 . This entails as returns on market go up, Tribune Publishing average returns are expected to increase less than the benchmark. However during bear market, the loss on holding Tribune Publishing Company will be expected to be much smaller as well. Additionally, the company has an alpha of 0.1691 implying that it can potentially generate 0.1691% excess return over Russell 2000 after adjusting for the inherited market risk (beta).
 Tribune Publishing  hype ideas   tribune publishing consumer cyclical publishing
  2 days ago at Macroaxis 
By Ellen Johnson
Today article will analyze 8 Construction Materials isntruments to have in your portfolio in November 2019. I will specifically cover the following equities: Norbord, Masonite International Corporat, Koppers Holdings Inc Koppers H, Cavco Industries, Masco Corporation, Enviva Partners LP, CRH PLC, and Caesarstone Ltd
 Macroaxis  thematic ideas   macroaxis
  2 days ago at Macroaxis 
By Vlad Skutelnik
In this article I will break down 7 Biotech isntruments to have in your portfolio in November 2019. I will cover Arrowhead Pharmaceuticals, Emergent Biosolutions, Neurocrine Biosciences, Corcept Therapeutics Incorporat, Cambrex Corporation, Seattle Genetics, and Novo Nordisk AS
 Macroaxis  thematic ideas   macroaxis
  2 days ago at Macroaxis 
By Vlad Skutelnik
In this article I will break down 8 Chemicals Makers isntruments to have in your portfolio in November 2019. I will cover Sherwin Williams Company, SYMRISE AG, NewMarket Corp, Chase Corporation, SHIN ETSU CHEMICAL CO, SYMRISE AG, Celanese Corporation Celanese C, and BASF SE
 Macroaxis  thematic ideas   macroaxis
  2 days ago at Macroaxis 
By Achuva Shats
This story covers 8 Baby Boomer Prospects isntruments to have in your portfolio in November 2019. Specifically, I will break down the following equities: Horizon Pharma Plc, Texas Instruments Incorporated, NVIDIA Corporation, WisdomTree Europe Hedged Equity, Akorn, Lululemon Athletica, Amgen, and Bank Of America Corporation
 Macroaxis  thematic ideas   macroaxis
  2 days ago at Macroaxis 
By Vlad Skutelnik
In this article I will break down 8 Healthcare isntruments to have in your portfolio in November 2019. I will cover BioScrip, Amedisys, Apollo Medical Holdings, Addus HomeCare Corporation, Hanger, Genomic Health, Community Health Systems, and Chemed Corp
 Macroaxis  thematic ideas   macroaxis
  2 days ago at Macroaxis 
By Ellen Johnson
Today post will go over ACEVO Glb. I will look into why albeit cyclical ACEVO Glb disturbance, the long term basic indicators of the fund are still strong. Despite latest abnormal performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors. What is ACEVO Glb Target Price Odds to finish over Current Price? Depending on normal probability distribution, the odds of ACEVO Glb to move above current price in 30 days from now is about 59.49%. The ACEVO Glb Healthcare Absolute probability density function shows the probability of ACEVO Glb Fund to fall within a particular range of prices over 30 days . Assuming 30 trading days horizon, ACEVO Glb Healthcare Absolute has beta of -0.0909 . This suggests as returns on benchmark increase, returns on holding ACEVO Glb are expected to decrease at a much smaller rate. During bear market, however, ACEVO Glb Healthcare Absolute is likely to outperform the market. Additionally, the company has a negative alpha implying that the risk taken by holding this equity is not justified. ACEVO Glb Healthcare is significantly underperforming Russell 2000 .
 ACEVO Glb  fundamentals ideas   acevo glb universal-investment gmbh sector equity healthcare

Share Stories

Syndicate Stories to major social sites

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Search macroaxis.com